Indegene Ltd
Company Profile
Business description
Indegene Ltd provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech, and medical devices companies, that assist them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products. Its portfolio of solutions covers all aspects of commercial, medical, regulatory, and R&D operations of life sciences companies. The company segment includes Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation, and Others. Key revenue is generated from the Omnichannel Activation segment.
Contact
Outer Ring Road
Aspen Block G4, 3rd Floor
Manyata Embassy Business Park
Nagawara
BengaluruKA560045
INDT: +91 8046744567
Sector
Healthcare
Stock type
Defensive
Industry
Health Information Services
Fiscal Year End
31 March 2026
Employees
5,181
Stocks News & Analysis
stocks
We take a different view to market on ASX bloodbath
stocks
BHP earnings weaker with lower iron ore prices more than offsetting higher copper volumes
stocks
Moated ASX player makes moves to support growth in China
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,170.80 | 3.00 | -0.03% |
| CAC 40 | 7,979.08 | 95.03 | 1.21% |
| DAX 40 | 24,423.07 | 108.30 | 0.45% |
| Dow JONES (US) | 44,922.27 | 10.45 | 0.02% |
| FTSE 100 | 9,189.22 | 31.48 | 0.34% |
| HKSE | 24,976.95 | 145.95 | -0.58% |
| NASDAQ | 21,314.95 | 314.82 | -1.46% |
| Nikkei 225 | 42,880.53 | 665.76 | -1.53% |
| NZX 50 Index | 13,071.30 | 142.62 | 1.10% |
| S&P 500 | 6,411.37 | 37.78 | -0.59% |
| S&P/ASX 200 | 8,910.20 | 14.00 | 0.16% |
| SSE Composite Index | 3,728.18 | 0.89 | 0.02% |